Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026)
Kodiak Sciences (KOD) reported Interest & Investment Income of $1.6 million for Q1 2026, up 2.43% on a YoY basis from $1.6 million in Q1 2025, and up 116.78% quarter-over-quarter from $757000.0 in Q4 2025.
Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026) Analysis & Trends
Kodiak Sciences has reported Interest & Investment Income for 9 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 2.43% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (down 51.52% YoY), and the FY2025 full-year result was $4.5 million, down 59.48% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.6 million, up from $757000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $4.7 million in Q2 2023, with the low at $76000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $2.4 million across 5 years, with a median of $2.5 million in 2022.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 10675.0% — and 2025, when it slumped 66.17%.
- Kodiak Sciences' Interest & Investment Income stood at $3.0 million in 2022, then advanced by 29.17% to $3.9 million in 2023, then slumped by 45.34% to $2.1 million in 2024, then plunged by 64.46% to $757000.0 in 2025, then surged by 116.78% to $1.6 million in 2026.
- The last three Interest & Investment Income figures came in at $1.6 million (Q1 2026), $757000.0 (Q4 2025), and $917000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 757,000.00 |
| Sep 30, 2025 | 917,000.00 |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 76,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 81,000.00 |